Published financial brief
3248B
DUSA PHARMACEUTICALS INC
- As of
- 2011-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
3 data notes
- Only 2 of 5 periods.
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
2 reported periods
| Metric | FY 20102010-12-31 | FY 20112011-12-31 |
|---|---|---|
| Financial statements | ||
| RevenueUSD millions | 36.9 | 43.9 |
| Cost of goods soldUSD millions | 6.8 | 6.4 |
| Selling, general and administrative expenseUSD millions | 27.3 | 30.6 |
| Depreciation and amortizationUSD millions | 0.4 | 0.4 |
| Net incomeUSD millions | 2.7 | 6.8 |
| Operating profit (EBIT)USD millions | 2.4 | 6.5 |
| Income taxesUSD millions | 0 | 0 |
| Short-term debtUSD millions | 0 | 0 |
| Long-term debtUSD millions | 0 | 0 |
| Cash and equivalentsUSD millions | 19.6 | 28.2 |
| ReceivablesUSD millions | 3.3 | 3.7 |
| InventoryUSD millions | 2.2 | 2.8 |
| PayablesUSD millions | 0.2 | 0.8 |
| Net property, plant and equipmentUSD millions | 1.6 | 1.6 |
| Capital expenditureUSD millions | 0.2 | 0.5 |
| Operating cash flowUSD millions | 3.3 | 6.9 |
| Prepaid expensesUSD millions | —missing | —missing |
| AccrualsUSD millions | 4.5 | 4.8 |
| EBITDAUSD millions | 2.7 | 6.9 |
| Working capitalUSD millions | 21 | 29.7 |
| Working capital requirementUSD millions | 5.3 | 5.7 |
| Total debtUSD millions | 0 | 0 |
| Free cash flowUSD millions | 3.1 | 6.4 |
| Unlevered free cash flowUSD millions | 2.5 | 6 |
| Returns and ratios | ||
| ROICratio | 34.1% | 87.8% |
| Pre-tax ROICratio | 34.1% | 87.8% |
| Effective tax rateratio | 0% | 0% |
| Revenue growthratio | —missing | 19.1% |
| EBIT / Revenueratio | 6.4% | 14.7% |
| Revenue / Invested capitalmultiple | 5.35× | 5.98× |
| Cogs Over Revenuesratio | 18.5% | 14.6% |
| Sga Over Revenuesratio | 74% | 69.7% |
| Da Over Revenuesratio | 1.1% | 1% |
| Nfa Over Revenuesratio | 4.3% | 3.6% |
| Wcr Over Revenuesratio | 14.4% | 13.1% |
| Debt Over Ebitdamultiple | 0× | 0× |
| St Debt Over Cashmultiple | 0× | 0× |
| Interest Over Ebitdamultiple | 0× | 0× |
| Interest Over Nocf Nicfmultiple | 0× | 0× |
| Nsf Over Wcrmultiple | -3.7× | -4.91× |
Ask this snapshot
Research assistant
3248B · annualSnapshot 2c390da2
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000